BBV Review

Advertisement
Response-guided therapy leads to complete cure after three weeks of all-oral triple-direct acting antiviral regimens in non-cirrhotic chronic hepatitis C genotype 1b Chinese subjects (SODAPI study)  
The diagnosis of HCV infection has high cost and is time consuming for clinical laboratories.The addition of HCV antigen testing to the battery of laboratory HCV tests and the application of a cost efficient testing algorithm warrants further consideration.

Twitter Updates

BBV Review @DrLoomba @JVLazarus There are more advanced ML & AI methods including LIVERFASt a product of Fibronostics which ha… https://t.co/hTlk8Bilc2
Monday, 15 February 2021 10:54
BBV Review RT @HenryEChang: HCV treatment in 2020: How to translate highly effective therapies into elimination strategies→https://t.co/gvgyBRaitj vi…
Friday, 04 September 2020 11:46
BBV Review RT @HenryEChang: Sustainable Development Goals for HBV elimination in South Africa: challenges, progress & the road ahead→https://t.co/TCu…
Wednesday, 22 May 2019 09:04
BBV Review RT @grahamscooke: Two helpful pieces on HCV reinfection from @GregDore2 @ProfJohnDillon at a time when we're trying to get access to retrea…
Sunday, 05 May 2019 13:34

Events & Conferences

For accurate and independent information on blood borne viruses, subscribe to our free newsletter.